Chemotherapy of leishmaniasis

Details Chemotherapy of leishmaniasis Chemotherapy of leishmaniasis

A - Human Necessities

61

K

167/126, 167/154

A61K 33/24 (2006.01) A61K 9/127 (2006.01) A61K 9/48 (2006.01) A61K 31/13 (2006.01) A61K 31/19 (2006.01) B01J 13/02 (2006.01)

Patent

CA 1093465

Abstract of the Disclosure An improved method is provided for the chemotherapy of leishmanial infections. The anti-leishmanial agent is encapsulated with liposomes and rhe liposome-encapsulated drug is injected into the body. Subject use of a liposome carrier has produced marked enhancement of the effectiveness and duration of anti-leishmanial action of meglumine antimoniate, end of sodium stibogluconate, drugs which are recommended widely for therapy of leishman- iesis.

315096

Affiliated with

Also associated with

Rating

Chemotherapy of leishmaniasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemotherapy of leishmaniasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemotherapy of leishmaniasis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1054240